Related references
Note: Only part of the references are listed.Immunomodulatory effects of antipsychotic treatment on gene expression in first-episode psychosis
Outi Mantere et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2019)
Peripheral Biomarkers for First-Episode Psychosis-Opportunities from the Neuroinflammatory Hypothesis of Schizophrenia
Nuno Trovao et al.
PSYCHIATRY INVESTIGATION (2019)
Immunoneuropsychiatry - novel perspectives on brain disorders
Katrin Pape et al.
NATURE REVIEWS NEUROLOGY (2019)
Neutrophil-to-lymphocyte ratio in schizophrenia: A systematic review and meta-analysis
Vasilios Karageorgiou et al.
SCHIZOPHRENIA RESEARCH (2019)
Profiling inflammatory signatures of schizophrenia: A cross-sectional and meta-analysis study
Dorota Frydecka et al.
BRAIN BEHAVIOR AND IMMUNITY (2018)
Inflammation in Schizophrenia: Pathogenetic Aspects and Therapeutic Considerations
Norbert Mueller
SCHIZOPHRENIA BULLETIN (2018)
The relationship between serum cytokine levels and degree of psychosis in patients with schizophrenia
Shani Dahan et al.
PSYCHIATRY RESEARCH (2018)
Towards an Immunophenotype of Schizophrenia: Progress, Potential Mechanisms, and Future Directions
Brian J. Miller et al.
NEUROPSYCHOPHARMACOLOGY (2017)
Unresolved Issues for Utilization of Atypical Antipsychotics in Schizophrenia: Antipsychotic Polypharmacy and Metabolic Syndrome
Sang Won Jeon et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
The Effect of Osteopontin on Microglia
Huan Yu et al.
BIOMED RESEARCH INTERNATIONAL (2017)
Osteopontin directly modulates cytokine expression of primary microglia and increases their survival
Monika Rabenstein et al.
JOURNAL OF NEUROIMMUNOLOGY (2016)
A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression
D. R. Goldsmith et al.
MOLECULAR PSYCHIATRY (2016)
Neuroimmune biomarkers in schizophrenia
Jakub Tomasik et al.
SCHIZOPHRENIA RESEARCH (2016)
Relationship between neutrophil/lymphocyte ratio with oxidative stress and psychopathology in patients with schizophrenia
Burak Kulaksizoglu et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2016)
Effects of Risperidone on Cytokine Profile in Drug-Naive First-Episode Psychosis
Cristiano Noto et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2015)
Osteopontin expression in acute immune response mediates hippocampal synaptogenesis and adaptive outcome following cortical brain injury
Julie L. Chan et al.
EXPERIMENTAL NEUROLOGY (2014)
Th17 Pathway-Mediated Immunopathogenesis of Schizophrenia: Mechanisms and Implications
Monojit Debnath et al.
SCHIZOPHRENIA BULLETIN (2014)
Decreased interleukin-10 serum levels in first-episode drug-naive schizophrenia: Relationship to psychopathology
Mei Hong Xiu et al.
SCHIZOPHRENIA RESEARCH (2014)
Increased inflammatory markers identified in the dorsolateral prefrontal cortex of individuals with schizophrenia
S. G. Fillman et al.
MOLECULAR PSYCHIATRY (2013)
The Neuroimmunology of Schizophrenia
Annya M. Smyth et al.
CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE (2013)
Meta-Analysis of Cytokine Alterations in Schizophrenia: Clinical Status and Antipsychotic Effects
Brian J. Miller et al.
BIOLOGICAL PSYCHIATRY (2011)
Is Depression an Inflammatory Disorder?
Charles L. Raison et al.
CURRENT PSYCHIATRY REPORTS (2011)
The role of osteopontin in inflammatory processes
Susan Amanda Lund et al.
JOURNAL OF CELL COMMUNICATION AND SIGNALING (2009)
Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration
Liya Qin et al.
GLIA (2007)
Elevated interleukin-2, interleukin-6 and interleukin-8 serum levels in neuroleptic-free schizophrenia: association with psychopathology
XY Zhang et al.
SCHIZOPHRENIA RESEARCH (2002)
Cytokines and the brain: Implications for clinical psychiatry
Z Kronfol et al.
AMERICAN JOURNAL OF PSYCHIATRY (2000)
Eta-1 (osteopontin): An early component of type-1 (cell-mediated) immunity
S Ashkar et al.
SCIENCE (2000)
Share Paper
